CLINICAL_TRIALS
trial_result
· 2011-01-05
Clinical Trial Update: Safety of Ertapenem in Beta-lactam Allergic Patients. [Phase 4]
Summary
A Phase 4 clinical trial update assessing the safety of ertapenem in patients with beta-lactam allergy, focusing on IgE-mediated hypersensitivity and allergic r…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Catholic University of the Sacred Heart | Conditions: IgE-Mediated Hypersensitivity, Allergy | Phase 4 | Status: UNKNOWN